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Abstract 
Background: Women affected by adversity, including gender-based violence, are at increased risk for developing 
common mental disorders such as depression, anxiety and posttraumatic stress disorder (PTSD). The World Health 
Organization (WHO) has developed Problem Management Plus (PM+), a 5-session, individual psychological interven-
tion program, that can be delivered by non-specialist counsellors that addresses common mental disorders in people 
affected by adversity. The objectives of this study are to evaluate effectiveness of PM+ among women who have 
been affected by adversity, including gender-based violence, and to perform a process evaluation.
Methods: Informed by community consultations, the PM+ manual has been translated and adapted to the local 
context. A randomized controlled trial will be carried out in the catchment areas of three local health care facilities 
in Dagoretti Sub County, Nairobi. After informed consent, females with high psychological distress (General Health 
Questionnaire-12 (score >2) and functional impairment (WHO Disability Assessment Schedule 2.0 score >16) will be 
randomised to PM+ (n = 247) or enhanced treatment as usual (n = 247). Post-treatment and 3-months post-treat-
ment follow-up assessments include psychological distress, functional disability, PTSD symptoms, perceived problems 
for which the person seeks help, health care use and health costs. For evaluating the process of implementing PM+ 
within local communities in Nairobi 20 key informant interviews will be carried out in participants, PM+ providers, 
decision makers, clinical staff.
Discussion: If PM+ is proven effective, it will be rolled out to other low and middle income areas and other popula-
tions for further adaptation and testing.
Trial registration Australian New Zealand Clinical Trials Registry, ACTRN12616000032459. Registered prospectively on 
January 18, 2016
Keywords: Low- and middle income countries, Trauma, Gender-based violence, Intimate partner violence, Cognitive 
behavioural therapy, Task-shifting, Non-specialist counsellors, Common mental disorders, Depression, Anxiety, 
Posttraumatic stress disorder
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Background
Gender-based violence (GBV) such as intimate partner 
violence or sexual violence by someone else is an increas-
ing global topic of concern. Worldwide, the estimated 
lifetime prevalence of GBV is at least 30 % [1–3] Women 
living in urban poverty—including slums—in low and 
middle income countries (LMICs) are especially vulner-
able for violence and common mental disorders, since 
poverty poses women at risk for experiencing gender-
based violence. In Kenya, 47 % of women reported hav-
ing experienced physical and/or sexual violence at some 
point in their lives.
Women exposed to GBV are at higher risk for devel-
oping common mental disorders such as depression, 
anxiety disorders, and posttraumatic stress disorder 
(PTSD) and make more use of health services than non-
abused women [2, 4, 5]. Common mental disorders are 
among the largest contributors to disability and func-
tional impairment (see Patel et  al. [6]). Additional con-
sequences of GBV involve reduced social and economic 
development prospects for women because of unwanted 
pregnancy, lack of resources, limited opportunities, 
concurrent physical health problems, low education, 
and fewer social supports [7, 8]. In most communities, 
women affected by GBV tend to receive no or minimal 
mental health support [1].
Effective interventions to treat common mental dis-
orders are available (e.g., cognitive behavioural therapy; 
CBT [9, 10]). However, these interventions typically 
require expert mental health professionals providing 
treatments that are usually lengthy and costly to the 
health service. LMICs lack sufficient numbers of spe-
cialized mental health care professionals to deliver such 
interventions and are unlikely to afford costs associated 
with scaling up intensive treatment programs in an effec-
tive but safe manner. For practically and sustainably scal-
ing-up evidence-based mental health care interventions 
in LMICs, interventions should be short and relatively 
easy to administer, so they can be carried out by non-
specialist helpers in the community, such as commu-
nity health workers (cf. [11]). In addition, interventions 
should not target one outcome (e.g. PTSD) but address a 
broader range of outcomes, including general functioning 
and common mental and psychosocial health problems.
World Health Organization (WHO) has developed a 
low-intensity 5-sessions program termed Problem Man-
agement Plus (PM+) which may be delivered by trained 
non-specialist helpers [12]. PM+ aims to reduce symp-
toms of depression, anxiety, PTSD, stress in the wake of 
adversity and trauma and to improve functioning. It com-
prises evidence-based techniques: of (a) problem solving, 
(b) stress management, (c) behavioral activation, and (d) 
accessing social support.
The impetus for developing the PM+ manual came 
from request to the Department of Mental Health and 
Substance Abuse at the WHO in Geneva to develop 
interventions for survivors of GBV that may be deliv-
ered in such manner that they are feasible in Sub-
Saharan Africa, where (a) health systems typically 
do not have the resources to make available proven 
psychological interventions on a routine basis (e.g. 
exposure therapy, cognitive processing therapy, Eye 
Movement Desensitization and Reprocessing), and (b) 
where social stigma against GBV can be so high that 
attending specific mental health care for GBV can 
put women at social risk (e.g., further violence, aban-
donment by the community). PM+ addresses these 
two requirements by involving relatively simple, non-
intrusive techniques that do not necessarily focus on 
the trauma of GBV. It can thus be offered outside of 
the context of vertical GBV-services by briefly trained 
but well-supervised helpers to most women impaired 
by distress, irrespective of the causes of the distress. 
Additionally, this study aims to test the capacity of 
PM+ to reduce mental disorders in women affected by 
GBV by screening for psychological distress in women 
in adversity-affected community settings; because this 
way of case identification potentially overcomes the 
barrier of GBV-survivors to seek mental health assis-
tance and reduces the risks of stigmatizing women 




This study aims to evaluate the effectiveness of the 
locally adapted version of PM+ in women affected 
by adversity and GBV in urban slum areas in Nairobi, 
Kenya in reducing symptoms of common mental dis-
orders. We will conduct a randomized controlled trial 
(RCT) comparing PM+ to enhanced treatment as usual 
(ETAU) in 494 study participants. See Fig.  1 for an 
overview of the design. In addition, we will perform a 
process evaluation to examine barriers and facilitators 
when implementing the RCT and the interventions in 
the chosen settings.
Setting
The study will be carried out in three local health care 
facilities that are part of the primary healthcare sys-
tem of the Dagoretti Sub County Nairobi in Kenya. 
Kenya is a LMIC; despite a growing middle class, 
almost half (45.9  %) of the population lives below the 
national poverty line. The study is overseen by staff of 
World Vision Kenya and their Riruta Area Develop-
ment Program, which is a geographic area where World 
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Vision implements long-term community development 
programs in collaboration with primary health care 
centres.
Participants
Participant inclusion criteria are: (a) adult (18  years or 
older) females; (b) score above 2 on a screening ques-
tionnaire for psychological distress (General Health 
Questionnaire-12; GHQ-12; and (c) score above 16 on 
a screening questionnaire for functional impairments 
(WHO Disability Assessment Schedule 2.0; WHODAS; 
[13]). These instruments are described below. Exclusion 
criteria are: (a) male gender; (b) acute medical condi-
tions; (c) risk of suicide; or (d) severe mental disorders or 
cognitive impairment (e.g., severe intellectual disability, 
dementia, psychosis).
Informed consent
Informed consent entails a two-step procedure: (1) 
Informed consent for screening and (2) Informed con-
sent for taking part in the PM+ trial. The latter is only 
required for participants meeting inclusion criteria. For 
each step respondents who decide to participate will be 
asked to complete a written consent form. Each person 
will be given at least 24 h to think whether she wants to 
take part in the PM+ trial. For participants who are illit-
erate, witnessed oral consent and a thumb print in lieu of 
a signature will be asked, in line with recommendations 
from WHO [14]. The witness will not be a member of the 
research team.
Procedure
Participants will be included through community 
screening at the homes of the participants by independ-
ent assessors. Assessors start sampling at a central point 
in the community and randomly select a direction in 
which to screen, selecting households using a popula-
tion-based interval approach. In this approach, mem-
bers from a larger population are selected according to 
a random starting point and a fixed, periodic interval 
(called the sampling interval), which is calculated by 
dividing the population size by the desired sample size. 
Thus, the sampling interval will vary depending on the 
population size of each of the three areas involved in the 
research.
After selecting the households, independent asses-
sors will identify and attempt to meet with the head of 
each household. The assessors explain the purpose of 
the survey and ask if they may interview a random adult 
woman aged 18  years or older from the household. If a 
household does not have a woman of 18 years or older, or 
the woman declines to be screened for the research, the 
enumerator moves on to the next household based on the 
sampling intervals.
The independent assessors will refer individuals meet-
ing any of the exclusion criteria to specialist support in 
the county according to their need. All interviews are 
conducted face-to-face in a private space (e.g. in people’s 
homes or in a quiet area near their homes). If partici-
pants are not selected because they score below the cut-
offs for either the GHQ-12 or the WHODAS, they will 
be provided feedback on their test outcomes and reasons 
why they are not eligible for the study will be explained to 
them. Next, the pre-assessment is completed by admin-
istering the PTSD Checklist for DSM-5 (PCL-5), Life 
Events Checklist (LEC), selected questions of the WHO 










































Fig. 1 Flow diagram
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the psychological outcome profiles instrument (PSY-
CHLOPS) and items derived from the Service Receipt 
Inventory (SRI).
The post-intervention assessment (WHODAS, GHQ-
12, PCL-5, PSYCHLOPS) is scheduled 7  weeks after the 
pre-intervention assessment (i.e., 1  week after the 5th 
PM+ session), and the follow-up assessment (WHODAS, 
GHQ-12, PCL-5, LEC, PSYCHLOPS, SRI) is scheduled 
at 13  weeks after the post-intervention assessment (i.e. 
20  weeks after inclusion, in line with the timing of the 
follow-up assessment for the PM+ participants). The par-
ticipants who receive PM+ will also be administered the 
PSYCHLOPS by the non-specialist helpers at the begin-
ning of each PM+ session. Table 1 presents an overview of 
measures that are administered at each of the assessments.
All instruments will be delivered in interview format 
as many participants are expected to be illiterate. Female 
independent assessors, most holding a tertiary-level degree 
in psychology or a related discipline, and fluent in Kiswa-
hili and English will carry out the screening and pre and 
post assessments. Assessors will have received a three-day 
training covering administering the instruments, common 
mental disorders, general interview techniques, and ethical 
research conduct. An additional one-day training in psy-
chological first aid and how to support women experienc-
ing emotional distress will also be provided for assessors. 
Ongoing monitoring of assessors’ competency will be con-
ducted through regular supervision by the trial manager. 
The assessors will be blind to the allocation status of the 
participants.
Sample size
A total number of 494 participants will to be included. 
Since we are not aware of intervention studies that have 
been carried out in this population, and we expect the 
population to be heterogeneous with respect to the 
types of common mental disorders, we aimed for a small 
to medium effect size of d =  0.04 in GHQ-12 symptom 
score in the PM+ group as compared to the control group 
at 3 months after the conclusion of the study. These esti-
mates are in line with the observed effectiveness of an 
intervention led by lay health counsellors for depressive 
and anxiety disorders in a study in primary care in India 
[15]. Power calculations suggest a minimum sample size 
of 133 participants per group (power = 0.95, alpha = 0.05, 
two-sided). Taking into account 30 % attrition at follow-
up, at least 346 participants (173 per group) need to be 
included. Further, since we estimate that 70 % of women 
in this distressed sample would have a history of GBV, we 
intend to include at least 494 women in the study.
Randomization
Randomization will occur following pre-assessment. This 
will be conducted by an independent research assistant 
located off-site (University of New South Wales) and not 
involved in any other aspects of the study. Randomiza-
tion will be performed using computerized software on 
a 1:1 basis.
The Problem Management Plus (PM+) program
The WHO PM+ program involves a set of a brief psy-
chological strategies that seek to ameliorate symptoms 
of common mental health problems (e.g. depression, 
anxiety, stress). The intervention protocol was written 
for WHO by a consultant of the University of New South 
Wales, Australia [12, 16].
The PM+ intervention protocol has been translated 
into Kiswahili and adapted to the local sociocultural con-
text of the lives of women in poor neighborhoods of Nai-
robi. The translation and adaptation have been reviewed 
in two workshops: one with experts on the intervention 
and the other with community representatives includ-
ing local leaders, local health care provides, community 
health workers (CHWs) and Kenyan translators [17].
PM+ integrates problem-solving and behavioral treat-
ment techniques that demonstrate amenability to low-
intensity delivery and are evidence-based [18–21]. PM+ is 
delivered over 5 weekly sessions of 90 min duration. Clients 
are systematically taught four strategies: (1) stress manage-
ment; (2) problem solving; (3) behavioral activation and 
(4) skills to strengthen social support. The PM+ program 
is being made available in different formats. In the current 
RCT, the PM+ individual version will be tested.
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PM+ providers will be female CHWs, who will be 
selected based on individual interviews. PM+ providers will 
meet the following criteria: (1) High school diploma (form 
4 level of education or above); (2) Reasonable proficiency 
in both Kiswahili and English language; (3) 1-year training 
post-secondary school as CHWs or health related career; 
(4) 2-years and above experience in community work; and 
(5) Already working as a CHW within a given geographical 
area. PM+ providers will receive a total of 2 weeks of train-
ing. In addition, one professional Kenyan supervisor will be 
employed for each of the three health facility areas.
Protocol adherence will be ensured by the supervisors 
and weekly group supervisions of the CHWs [22]. Super-
visors will receive weekly supervision and on-the-job 
training in supervision skills by the project intervention 
consultant (KSD).
To evaluate treatment fidelity, 10  % of all PM+ ses-
sions will be attended by the supervisor, using a checklist 
to ensure basic elements of the PM+ intervention have 
been followed as required.
At the beginning of every PM+ session the PSY-
CHLOPS will be administered. This instrument, in con-
trast to above named instruments will be administered 
by the CHW to assess and monitor progress on problems 
for which the person seeks help.
Enhanced treatment-as-usual (ETAU)
Treatment-as-usual in primary healthcare centers in Nai-
robi, Kenya to individuals with common mental disor-
ders usually consists of no or placebo treatment. For this 
study, treatment as usual will be substantially enhanced. 
Participants in the ETAU group will be referred to their 
primary care clinicians (usually nurses) for follow-up. 
These primary care nurses will have received a 3-day 
training; 1  day on basic psychological first aid commu-
nication skills and building on this with training from 
the International Federation of Red Cross non-specific 
lay-counselling resource [23]. This resource focuses on 
ethical considerations for lay counsellors, structuring a 
helping conversation and referral for high care.
We will seek to keep track of the types and amount of 
support participants receive through the SRI. If, during 
this treatment or during the study’s assessments partici-
pants in ETAU arm show severe psychiatric disorders 
or problems (e.g., psychosis or suicidality) that require 
immediate specialist treatment and follow-up, they will 
be referred to the subcounty hospital, which has been 
contracted to provide gratis care to the participants 
referred for these problems.
Screening measures
The WHODAS [13] is a generic assessment instrument 
assessing general functioning, health and disability. 
Simple to administer, it is applicable across all health 
states, including mental disorders, and across cultures. 
WHODAS covers six domains (cognition, mobility, self-
care, getting along, life activities, and participation). It 
assesses difficulties people have due to their illness across 
these domains during the last 30  days. Difficulties are 
scored as none, mild, moderate, severe, or extreme. We 
will use the 12-item interviewer administered version. 
The WHODAS has been validated in Kenya.
The GHQ-12 [24, 25] assesses level of general psycho-
logical distress during screening. The GHQ-12 consists 
of 12 questions that are scored on a 4-point scale rang-
ing from 0 to 3. The total GHQ-12 score is obtained by 
summing up the scores of the individual items and ranges 
between 0 and 36 with higher scores representing higher 
levels of distress. When used as a screening tool, the 
GHQ-12 is usually scored bi-modally (i.e.-0-0-1-1), and 
ranges between 0 and 12. In a previous study in Kenya, 
a cut-off of higher than 2 has been reported to indicate 
clinical levels of distress [26].
Data on socio-demographic information (sex, age, edu-
cation, marital status and work status) will be collected 
through questions A1-A5 of the WHODAS.
Primary outcomes
Primary outcomes are the level of psychological distress 
as measured with the GHQ-12 at 3  months follow-up 
(i.e., 3  months after the 5th PM+ session) and general 
functioning as measured with the WHODAS.
Secondary outcomes
Posttraumatic stress disorder (PTSD) symptoms will 
be measured using the PCL-5 [27], which is a 20-item 
checklist corresponding with the 20 DSM-5 PTSD symp-
toms. Items are rated on a 0–4 scale and add up to a 
total severity score of 80. The PCL-5 will be adapted to 
ask for symptoms in the last week (rather than month) to 
enhance sensitivity to change.
PSYCHLOPS [28] will be administered at all assess-
ments and at the beginning of each PM+ session, and 
assesses progress on problems for which the person seeks 
help. It consists of four questions that encompass three 
domains: problems (2 questions), functioning (1 ques-
tion) and wellbeing (1 question). Participants are asked 
to give free text responses to the problem and function 
domains. Responses are scored on an ordinal six-point 
scale producing a maximum score of 20 (5 points per 
question). The PSYCHLOPs version administered at 
posttreatment and follow-up also includes an overall val-
uation question (determining self-rated outcome ranging 
from “much better” to “much worse”). PSYCHLOPS has 
been validated in primary care populations across several 
countries.
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Other measures
Previous stressor exposure will be assessed using the 
LEC [29]. This is a widely used list of 17 experienced or 
witnessed events, such as rape, serious injury, combat 
exposure, or the sudden death of a loved one. A Kiswahili 
version of this list is available [30]. At post-test the ques-
tion phrasing will be adapted to capture life events that 
have occurred since commencing in the trial.
Five key questions of the Swahili version of the WHO-
VAW as developed for use in the WHO Multi-Country 
Study on Women’s Health and Domestic Violence [31] 
are administered.
Indicators of economic impact will be assessed using 
the WHODAS question on days out of role and by 
selected SRI [32] questions on health care service use.
Process evaluation
The feasibility, and difficulties and successes in car-
rying out research and intervention activities will be 
explored through semi-structured interviews with 
20 key informants, including 5 CHWs. The burden 
of completing the assessments and PM+ on the time 
and effort of participants, satisfaction with the inter-
vention, and barriers and facilitators to adherence will 
be explored through semi-structured interviews with 
a sample of 5 participants (including participants that 
have dropped out). In addition, 5 decision-makers with 
responsibilities for developing or implementing health 
policy, including heads of the relevant clinics, and 5 
PHC staff (clinical officers/nurses) will be interviewed 
to obtain their perceptions of the benefits and chal-
lenges of integrating PM+ into the CHWs routine ser-
vice provision.
Analysis
To determine comparability between the conditions at 
baseline, multiple planned comparisons will be con-
ducted for continuous variables and Chi squared tests for 
categorical ones.
Hierarchical linear modeling (HLM) analysis will be 
carried out to assess differential change over time in 
GHQ, WHODAS, and PSYCHLOPS scores between 
groups. For each outcome, the effects of time of meas-
urement, group, and the group-by-time interaction will 
be analyzed. HLM presumes intent-to-treat analyses as 
HLM allows the number of observations to vary between 
participants and effectively handles missing data. Time 
(linear and quadratic), treatment condition, and their 
interaction will be included in the models. Fixed effects 
parameters will be tested at 95 %CI. The Level 1 model 
will represent within-patient change over time, and the 
Level 2 model will predict variation in within-patient 
change over time and encompass between-patient 
variables. Outcome analyses will be reported primarily 
in women reporting GBV, and secondarily for women 
affected by all forms of adversity.
Descriptive analyses will be carried out in SPSS and 
HLM analyses in Stata version 11.2. Across all analyses, 
two-tailed tests will be reported with p < 0.05.
Adverse events reporting
All adverse reactions and serious adverse events (SAEs) 
reported spontaneously by the subject or observed by the 
investigators or other staff members will be recorded by 
the research team. A SAE is an undesirable experience 
occurring to a subject during the study, whether or not 
considered related to the research procedure. Although it 
is unlikely that SAEs would occur given the nature of the 
intervention, all adverse events and SAEs will be reported 
to the local independent advisory board. This board will 
consist of the supervisor, the study coordinator and an 
independent medical professional from the local health 
facility. The chair or a nominated person from the advisory 
board will review SAEs within 48 h and the advisory board 
will review all AEs twice a month and where necessary 
to determine any appropriate action in respect of ongo-
ing trial conduct. On the informed consent form, patient 
information is included to inform participants that the field 
coordinator, or another clinician other than their therapist 
are available to them if they are upset by this study.
Ethics
The project has been approved locally by the Research 
Ethics Committee of the Great Lakes University of 
Kisumu, Kenya and by the WHO Ethical Review Com-
mittee (Protocol ID: RPC656, April 25, 2014, Amend-
ment February 16, 2015).
Discussion
By evaluating the effectiveness of PM+ in women 
affected by gender-based violence in Nairobi, Kenya, 
we seek to address the need for access to brief, effective 
psychological interventions that can be administered by 
non-professional health workers in LMICs. A second 
RCT on the effectiveness of individually delivered PM+ 
in males and females in an humanitarian setting in Pesha-
war, Pakistan is underway [33]. If proven effective, PM+ 
may not only be used in similar areas in Kenya and Paki-
stan, but rolled out to other affected areas in both LMIC 
settings and high-resource countries for further adapta-
tion. It may be a useful intervention for humanitarian 
settings (e.g., conflict settings) where mental health care 
for GBV-survivors is often lacking. PM+ may be tested 
in different formats (e.g., internet-delivered, group or 
young adolescent version) across a variety of populations 
suffering from psychological distress. The PM+ manual 
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and accompanying training materials, if proven effective, 
will be published by WHO and will be made available on 
WHO’s website, in order to enable future scaling-up.
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